These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16216895)

  • 1. Bone mineral density decrements and children diagnosed with cancer.
    Pagano-Therrien J; Santacroce SJ
    J Pediatr Oncol Nurs; 2005; 22(6):328-38. PubMed ID: 16216895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the treatment for childhood solid tumors associated with lower bone mass than that for leukemia and Hodgkin disease?
    Muszynska-Roslan K; Konstantynowicz J; Panasiuk A; Krawczuk-Rybak M
    Pediatr Hematol Oncol; 2009 Jan; 26(1):36-47. PubMed ID: 19206007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Little evidence of low bone mass in acute lymphoblastic leukemia survivors.
    Muszynska-Roslan K; Panasiuk A; Latoch E; Krawczuk-Rybak M; Konstantynowicz J
    J Clin Densitom; 2012; 15(1):108-15. PubMed ID: 21880524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skeletal morbidity in childhood acute lymphoblastic leukemia.
    Mandel K; Atkinson S; Barr RD; Pencharz P
    J Clin Oncol; 2004 Apr; 22(7):1215-21. PubMed ID: 15051768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
    Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
    Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone mineral density and serum bone turnover markers in survivors of childhood acute lymphoblastic leukemia: comparison of megadose methylprednisolone and conventional-dose prednisolone treatments.
    Alikasifoglu A; Yetgin S; Cetin M; Tuncer M; Gumruk F; Gurgey A; Yordam N
    Am J Hematol; 2005 Oct; 80(2):113-8. PubMed ID: 16184587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteopenia, physical activity and health-related quality of life in survivors of brain tumors treated in childhood.
    Odame I; Duckworth J; Talsma D; Beaumont L; Furlong W; Webber C; Barr R
    Pediatr Blood Cancer; 2006 Mar; 46(3):357-62. PubMed ID: 16035080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of bone mineral density and risk factors in children completing treatment for acute lymphoblastic leukemia.
    Gunes AM; Can E; Saglam H; Ilçöl YO; Baytan B
    J Pediatr Hematol Oncol; 2010 Apr; 32(3):e102-7. PubMed ID: 20216235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone mineral density in childhood acute lymphoblastic leukemia (ALL) during and after treatment.
    van der Sluis IM; de Muinck Keizer-Schrama SM; van den Heuvel-Eibrink MM
    Pediatr Blood Cancer; 2004 Aug; 43(2):182-3; discussion 184. PubMed ID: 15236291
    [No Abstract]   [Full Text] [Related]  

  • 10. Bone mineral density deficits in survivors of childhood cancer: long-term follow-up guidelines and review of the literature.
    Wasilewski-Masker K; Kaste SC; Hudson MM; Esiashvili N; Mattano LA; Meacham LR
    Pediatrics; 2008 Mar; 121(3):e705-13. PubMed ID: 18310191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial investigating an exercise program to prevent reduction of bone mineral density and impairment of motor performance during treatment for childhood acute lymphoblastic leukemia.
    Hartman A; te Winkel ML; van Beek RD; de Muinck Keizer-Schrama SM; Kemper HC; Hop WC; van den Heuvel-Eibrink MM; Pieters R
    Pediatr Blood Cancer; 2009 Jul; 53(1):64-71. PubMed ID: 19283791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone mineral density and osteonecrosis in survivors of childhood allogeneic bone marrow transplantation.
    Kaste SC; Shidler TJ; Tong X; Srivastava DK; Rochester R; Hudson MM; Shearer PD; Hale GA
    Bone Marrow Transplant; 2004 Feb; 33(4):435-41. PubMed ID: 14716354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of bone mineral density at different phases of therapy of childhood all.
    Maniadaki I; Stiakaki E; Germanakis I; Kalmanti M
    Pediatr Hematol Oncol; 2006; 23(1):11-8. PubMed ID: 16326407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone mineral density in newly diagnosed children with neuroblastoma.
    Al-Tonbary YA; El-Ziny MA; Elsharkawy AA; El-Hawary AK; El-Ashry R; Fouda AE
    Pediatr Blood Cancer; 2011 Feb; 56(2):202-5. PubMed ID: 21157889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone mineral decrements in survivors of childhood acute lymphoblastic leukemia: frequency of occurrence and risk factors for their development.
    Kaste SC; Jones-Wallace D; Rose SR; Boyett JM; Lustig RH; Rivera GK; Pui CH; Hudson MM
    Leukemia; 2001 May; 15(5):728-34. PubMed ID: 11368432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal bone mineral density after treatment for childhood acute lymphoblastic leukemia diagnosed between 1991 and 1998.
    Kadan-Lottick N; Marshall JA; Barón AE; Krebs NF; Hambidge KM; Albano E
    J Pediatr; 2001 Jun; 138(6):898-904. PubMed ID: 11391336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alendronate for steroid-induced osteopenia in children with acute lymphoblastic leukaemia or non-Hodgkin's lymphoma: results of a pilot study.
    Wiernikowski JT; Barr RD; Webber C; Guo CY; Wright M; Atkinson SA
    J Oncol Pharm Pract; 2005 Jun; 11(2):51-6. PubMed ID: 16460605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone mineral density in long-term survivors of childhood cancer.
    Arikoski P; Voutilainen R; Kröger H
    J Pediatr Endocrinol Metab; 2003 Mar; 16 Suppl 2():343-53. PubMed ID: 12729414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and etiology of low bone mineral density in juvenile systemic lupus erythematosus.
    Compeyrot-Lacassagne S; Tyrrell PN; Atenafu E; Doria AS; Stephens D; Gilday D; Silverman ED
    Arthritis Rheum; 2007 Jun; 56(6):1966-73. PubMed ID: 17530722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of abnormal bone density of pediatric patients prior to blood or marrow transplant.
    Klopfenstein KJ; Clayton J; Rosselet R; Kerlin B; Termuhlen A; Gross T
    Pediatr Blood Cancer; 2009 Oct; 53(4):675-7. PubMed ID: 19533650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.